Company DreamCIS, Inc.

Equities

A223250

KR7223250002

Healthcare Facilities & Services

End-of-day quote Korea S.E. 06:00:00 2024-05-30 pm EDT 5-day change 1st Jan Change
3,260 KRW -0.15% Intraday chart for DreamCIS, Inc. -2.69% +0.15%

Business Summary

DreamCIS Inc is a Korea-based company principally engaged in the business of contract clinical trial. The Company mainly provides services include regulatory post-marketing surveillance (rPMS), clinical trial, non-interventional study (NIS) and others. The Company provides its services within domestic market and to overseas markets.

Number of employees: 236

Sales per Business

KRW in Million2022Weight2023Weight Delta
Clinical Trial Agencies
71.9 %
32,200 82.8 % 34,424 71.9 % +6.90%
Medical Consulting
31.6 %
7,250 18.6 % 15,142 31.6 % +108.86%
Inter-Sector Transactions
-3.6 %
-577 -1.5 % -1,721 -3.6 % +198.48%

Sales per region

KRW in Million2022Weight2023Weight Delta
South Korea
100.0 %
38,874 100.0 % 47,844 100.0 % +23.08%

Managers

Managers TitleAgeSince
Chief Executive Officer 56 -
Director of Finance/CFO 55 -

Members of the board

Members of the board TitleAgeSince
Chief Executive Officer 56 -
Director/Board Member 43 -
Director of Finance/CFO 55 -
Director/Board Member 56 -
Director/Board Member 56 -
Director/Board Member 51 -

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 23,709,280 6,675,968 ( 28.16 %) 0 28.16 %

Shareholders

NameEquities%Valuation
14,123,680 59.57 % 31 M ₩
Master Union Holdings Ltd.
7.191 %
1,704,960 7.191 % 4 M ₩
1,159,072 4.889 % 3 M ₩
655,076 2.763 % 1 M ₩
45,600 0.1923 % 99 310 ₩

Holdings

NameEquities%Valuation
655,076 2.76% 1,426,657 $

Company contact information

DreamCIS, Inc.

Unit 1010, Jeukseon-Hyundai Building 130 Sajik-ro

03170, Seoul

+

http://www.dreamcis.com
address DreamCIS, Inc.(A223250)